rs61747875

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012293.3(PXDN):​c.4124C>T​(p.Thr1375Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,613,964 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1375P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0078 ( 18 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 17 hom. )

Consequence

PXDN
NM_012293.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.21

Publications

3 publications found
Variant links:
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
PXDN Gene-Disease associations (from GenCC):
  • anterior segment dysgenesis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029197633).
BP6
Variant 2-1638928-G-A is Benign according to our data. Variant chr2-1638928-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00783 (1192/152306) while in subpopulation AFR AF = 0.0263 (1091/41558). AF 95% confidence interval is 0.025. There are 18 homozygotes in GnomAd4. There are 582 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PXDNNM_012293.3 linkc.4124C>T p.Thr1375Ile missense_variant Exon 21 of 23 ENST00000252804.9 NP_036425.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PXDNENST00000252804.9 linkc.4124C>T p.Thr1375Ile missense_variant Exon 21 of 23 1 NM_012293.3 ENSP00000252804.4
PXDNENST00000478155.5 linkn.3212C>T non_coding_transcript_exon_variant Exon 13 of 15 2
PXDNENST00000453308.1 linkn.224+374C>T intron_variant Intron 2 of 3 3 ENSP00000414098.1

Frequencies

GnomAD3 genomes
AF:
0.00773
AC:
1177
AN:
152188
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0260
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00227
AC:
567
AN:
249300
AF XY:
0.00180
show subpopulations
Gnomad AFR exome
AF:
0.0291
Gnomad AMR exome
AF:
0.00188
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000327
Gnomad OTH exome
AF:
0.00116
GnomAD4 exome
AF:
0.00110
AC:
1613
AN:
1461658
Hom.:
17
Cov.:
35
AF XY:
0.00102
AC XY:
744
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.0296
AC:
991
AN:
33474
American (AMR)
AF:
0.00217
AC:
97
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5768
European-Non Finnish (NFE)
AF:
0.000235
AC:
261
AN:
1111832
Other (OTH)
AF:
0.00368
AC:
222
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
88
176
265
353
441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00783
AC:
1192
AN:
152306
Hom.:
18
Cov.:
33
AF XY:
0.00782
AC XY:
582
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0263
AC:
1091
AN:
41558
American (AMR)
AF:
0.00392
AC:
60
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000470
AC:
32
AN:
68026
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
58
116
173
231
289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00280
Hom.:
12
Bravo
AF:
0.00895
ESP6500AA
AF:
0.0241
AC:
103
ESP6500EA
AF:
0.000589
AC:
5
ExAC
AF:
0.00284
AC:
344
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 28, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Anterior segment dysgenesis 7 Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.0
DANN
Benign
0.79
DEOGEN2
Benign
0.020
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.37
T
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
3.2
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.088
Sift
Benign
0.17
T
Sift4G
Benign
0.25
T
Polyphen
0.018
B
Vest4
0.13
MVP
0.15
MPC
0.44
ClinPred
0.0041
T
GERP RS
3.0
Varity_R
0.030
gMVP
0.40
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61747875; hg19: chr2-1642700; API